|
|
Jin Yoshida, Genshin Tei et.al
Use of a Closed System Device to Reduce Occupational Contamination and Exposure to Antineoplastic Drugs in the Hospital Work Environment.
Ann. Occup. Hyg. Vol 53, No2, pp 153-160, 2009.
K. De Prijck, E. D´Haese, J Vandenbroucke, W Coucke, H Robays and H.J Nelis
Microbiological challenge of four protective devices for the reconstitution of cytotoxic agents.
The Society for Applied Microbiology, Letters in Applied Microbiology 47 (2008) 543-548.
Johan Vandenbroucke, PharmD; Hugo Robays, PharmD
Economic impact of the preparation scenario for cytotoxic drugs: an observational study.
EJHP Practice, Volume 14, 2008, Issue 5.
James A. Jorgenson, RPh, MS, FASHP; Susan Spivey, RPh, DDS, PharmD; Cam Au, PharmD; David Canann, PharmD; Howard Ritter, PharmD; Bart Smith, Senior Pharmacy Intern.
Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs.
Hospital Pharmacy, Volume 43, Number 9, pp 723-727, September 2008.
James A. Jorgenson, RPh, MS, FASHP. Leakproof Connection Integrity Test for Devices Intended for Handling Hazardous Drugs. Presented at the ASHP Midyear Clinical Meeting, December 2007.
James A. Jorgenson, RPh, MS, FASHP. 2007 Utah Protocol Update: Evaluation of Vial Transfer Devices for Containment of Hazardous Drug Vapors. Presented at ASHP Midyear Clinical Meeting, December 2007.
Spivey Susan, RPh, DDS, PharmD and Jorgenson A. James, RPh, MS, FASHP.
Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs.
Presented at the Oncology Nursing Society, 32nd Annual Congress, April 24–27, 2007, Las Vegas, NV.
Nyman A. Heather, PharmD, Jorgenson A. James, MS, FASHP, and Slawson H. Matthew, PhD. Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device. Hospital Pharmacy, Volume 42, Number 3, pp 219–225, 2007.
Cam Au, James Jorgenson, Bart Smith. Evaluation of Vial Transfer Devices for Containment of Hazardous Drug Vapors. Presented at UHC Resident Poster Session, ASHP Mid Year Clinical Meeting, December 3-7, 2006, Anaheim CA.
Ladda ned
Se video (QuickTime)
Kimberly M. Landini. Implementation of a safety device for use in preparing and administering cytotoxic medications in an inpatient setting (P360D). ASHP Abstracts & Program Resources on CDROM 2006 Midyear Clinical Meeting December 3-7, 2006, Anaheim CA.
Ladda ned
H. Miyamatsu, M. Sakamoto, K. Azuma, F. Ishii, A. Mae, K. Satou, C. Koura, K. Kouno, K. Saito, M. Abe, T. Akashi Evaluation of Operability of the PhaSeal system, a Sealed Handling Device for Anticancer Agents Japanese Journal of Pharmaceutical Health Care and Sciences (Vol.32, No.12, December 2006).
Bruce R. Harrison, Byron G. Peters and Michael R. Bing. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. American Journal of Health-System Pharmacy, Vol. 63, Issue 18, 2006, 1736-1744.
Abstrakt
Poirier S, Jones C, Calvert MJ. Practica implementation of a closed system (PhaSeal) for the preparation, administration and disposal of cytotoxic drugs in a busy ambulatory cancer centre. J Oncol Pharm Practice, Vol 10:No 2, 2004 p81.
Abstrakt
Tans Birgit, Willems Ludo. Comparative contamination study with cyclophosphamide, fluorouracil and ifosfamide: standard versus a proprietary closed-handling system. J Oncol Pharm Practice, Vol 10: No 4, 2004 p217-223.
Spivey S, Connor TH (2003) Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hosp Pharm 2003, 38(2):135-139.
Abstrakt
Wick C, Slawson MH, Jorgenson JA, Tyler LS (2003) Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm 60:2314-2320.
Abstrakt
Connor TH, Anderson RW, Sessink PJM and Spivey SM. Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area. Am J Health-Syst Pharm - Vol 59, Jan 1, 2002;59:68-72.
Abstrakt
Nygren O, Gustavsson B, Ström I, Eriksson R, Jarneborg, Friberg A. Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and closed system. J. Environ. Monit, 2002,4, 739-742.
Abstrakt
Vandenbroucke J. How to protect environment and employees against cytotoxic agents, the UZ Ghent experience. J Oncol Pharm Pratice, Vol 6, No 4, 2001: pp 146-152.
Abstrakt
Ferencak H. Alissa, Kopp A. Monica, Hausermann M. Donna. Implementation of Safer Chemotherapy Systems Utilized in a VA Medical Center. Presented at ASHP Midyear Meeting, 2000.
Sessink PJM, Rolf ME, Ryden NS. Evaluation of the PhaSeal Hazardous Drug Containment System. Hospital Pharmacy Vol 34 No. 11 Nov 1999, 1311-1317.
Abstrakt
Nygren O, Kragh E, Lundgren C, et al.
Presentation 1: Determination of spill and airborne emission during preparation of drugs using different preparation techniques;
Presentation 2: Emission and leakage during preparation of cytotoxic drugs.
International symposium on modern principles of workplace air moni to ring, 3:rd, Geilo, Norway, 1999.
Gustavsson B. Evaluation of technetium assay for monitoring of occupational exposure to cytotoxic drugs. J Oncol Pharm Practice 1997; 3: 46.
Abstrakt
ASHP Guidelines on handling hazardous drugs. Developed by the ASHP Council on professional affairs and approved by the ASHP board of directors on January 12 2006. Am J Health-Syst Pharm. 2006;63:1172-93.
Ladda ned
|
